Clinical Trial Update: A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial assessing YM150 for prevention of venous thromboembolism in patients undergoing major abdominal surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• YM150

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED